Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewGastroenterologyOncology Open Access | 10.1172/JCI204312

METTL1-mediated m7G modification of valine tRNAs drives metabolic adaptation in pancreatic ductal adenocarcinoma

Jiabei Zhu,1 Qi Zhang,2 Douglas Evans,3 Rui Su,4 Qiuhui Pan,2 and Ajay Goel1

1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America

2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China

3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America

4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America

Find articles by Zhu, J. in: PubMed | Google Scholar

1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America

2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China

3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America

4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America

Find articles by Zhang, Q. in: PubMed | Google Scholar

1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America

2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China

3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America

4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America

Find articles by Evans, D. in: PubMed | Google Scholar

1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America

2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China

3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America

4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America

Find articles by Su, R. in: PubMed | Google Scholar

1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America

2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China

3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America

4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America

Find articles by Pan, Q. in: PubMed | Google Scholar

1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America

2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China

3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America

4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America

Find articles by Goel, A. in: PubMed | Google Scholar |

Published August 11, 2026 - More info

J Clin Invest. https://doi.org/10.1172/JCI204312.
Copyright © 2026, Zhu et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published August 11, 2026 - Version history
View PDF
Abstract

Transfer RNA (tRNA) modifications play a critical role in regulating codon-specific mRNA translation and enabling tumor cell adaptation. The RNA methyltransferase METTL1 installs N7-methylguanosine (m⁷G) modifications on tRNAs, thereby shaping codon usage and translational output. However, the function and mechanistic contribution of the METTL1–tRNA axis in pancreatic ductal adenocarcinoma (PDAC) remain poorly defined. Here, we show that METTL1 is overexpressed in PDAC tissues and that elevated METTL1 expression is associated with poor patient survival. Genetic ablation of METTL1 markedly suppresses PDAC cell proliferation, migration, and tumor growth in vitro and in vivo. Mechanistically, METTL1 loss selectively reduces m⁷G-modified valine tRNAs – particularly, Val-AAC, Val-CAC, and Val-TAC – leading to impaired translation of valine-enriched oxidative phosphorylation transcripts. As a consequence, METTL1 deficiency disrupts mitochondrial respiration and energy production in PDAC cells. Consistent with this model, valine tRNA levels are elevated in PDAC tissues, and their selective depletion phenocopies METTL1 loss by impairing mitochondrial bioenergetics and tumor cell fitness. Thus, the METTL1–valine tRNA axis promotes PDAC progression through codon-dependent translational control of mitochondrial electron transport chain and oxidative metabolism. Together, our findings identify a METTL1–tRNA–mitochondrial signaling axis as a previously unrecognized metabolic vulnerability and a promising therapeutic target in pancreatic cancer.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View

View Supplementary Tables

Version history
  • Version 1 (August 11, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts